D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 30,804 336 World Ranking 9994 National Ranking 25

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Gene
  • Internal medicine

The scientist’s investigation covers issues in Cervical cancer, Internal medicine, HPV infection, Immunology and Papillomaviridae. Her Cervical cancer course of study focuses on Epidemiology and Sex organ and Etiology. Her Internal medicine research integrates issues from Oncology and Vaccine efficacy.

Luisa L. Villa interconnects Incidence, Young adult, Gynecology, Disease and Prospective cohort study in the investigation of issues within HPV infection. The concepts of her Immunology study are interwoven with issues in Papillomavirus Vaccines and Human papillomavirus. Luisa L. Villa has researched Papillomaviridae in several fields, including Cervix, Genome, Phylogenetic tree and Phylogenetics.

Her most cited work include:

  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (1649 citations)
  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial (1372 citations)
  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up (708 citations)

What are the main themes of her work throughout her whole career to date?

Luisa L. Villa mainly focuses on HPV infection, Cervical cancer, Internal medicine, Gynecology and Immunology. Her HPV infection study combines topics in areas such as Young adult, Papillomaviridae, Sex organ and Incidence. Her studies in Cervical cancer integrate themes in fields like Odds ratio, Epidemiology and Vaccination.

Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Her Gynecology research is multidisciplinary, relying on both Cervix, Prospective cohort study, Risk factor and Obstetrics. Her research investigates the connection with Human papillomavirus and areas like Virology which intersect with concerns in Polymerase chain reaction and Genome.

She most often published in these fields:

  • HPV infection (34.99%)
  • Cervical cancer (29.79%)
  • Internal medicine (23.88%)

What were the highlights of her more recent work (between 2015-2021)?

  • HPV infection (34.99%)
  • Internal medicine (23.88%)
  • Sex organ (13.71%)

In recent papers she was focusing on the following fields of study:

Her main research concerns HPV infection, Internal medicine, Sex organ, Cervical cancer and Cancer research. Her work carried out in the field of HPV infection brings together such families of science as Incidence, Young adult, Immunology, Gynecology and Genital warts. Her Gynecology research incorporates themes from Poisson regression and Anal cancer.

Luisa L. Villa combines subjects such as Gastroenterology and Oncology with her study of Internal medicine. Her Sex organ research includes elements of Hpv types, Genotyping, Epidemiology and Cohort study. Her Cervical cancer and Cervical intraepithelial neoplasia and Papillomaviridae investigations all form part of her Cervical cancer research activities.

Between 2015 and 2021, her most popular works were:

  • Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study (121 citations)
  • ICTV Virus Taxonomy Profile: Papillomaviridae. (48 citations)
  • Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. (37 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Her primary areas of study are HPV infection, Sex organ, Gynecology, Cervical cancer and Internal medicine. The HPV infection study combines topics in areas such as Young adult, Prospective cohort study, Incidence and Genital warts. The study incorporates disciplines such as Genotyping and Obstetrics in addition to Sex organ.

Her Gynecology research is multidisciplinary, incorporating perspectives in Test and Follow up studies. Her research on Cervical cancer focuses in particular on Papillomaviridae. Her research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Human papillomavirus, Clinical efficacy, Clinical trial, HPV vaccines and Cancer prevention.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)

2710 Citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)

1902 Citations

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer

Eduardo L. Franco;Luisa L. Villa;Joao P. Sobrinho;José M. Prado.
The Journal of Infectious Diseases (1999)

886 Citations

HPV type-distribution in women with and without cervical neoplastic diseases

Gary Clifford;Silvia Franceschi;Mireia Diaz;Nubia Munoz.
Vaccine. Supplement (2006)

815 Citations

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.

Nicolas F. Schlecht;Sophie Kulaga;Juliette Robitaille;Silvaneide Ferreira.
JAMA (2001)

802 Citations

Updating the natural history of HPV and anogenital cancer

Anna-Barbara Moscicki;Mark Schiffman;Susanne Kjaer;Luisa L. Villa.
Vaccine. Supplement (2006)

793 Citations

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Gary Clifford;Silvia Franceschi;Mireia Diaz;Nubia Muñoz.
Vaccine (2006)

713 Citations

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade.
British Journal of Cancer (2006)

708 Citations

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa.
Vaccine (2006)

625 Citations

Chapter 5: Updating the natural history of HPV and anogenital cancer.

Anna-Barbara Moscicki;Mark Schiffman;Susanne Kjaer;Luisa L. Villa.
Vaccine (2006)

550 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Luisa L. Villa

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 167

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 160

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 151

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 123

François Coutlée

François Coutlée

University of Montreal

Publications: 114

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 107

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 102

Robert D. Burk

Robert D. Burk

Albert Einstein College of Medicine

Publications: 102

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 97

Susanne K. Kjaer

Susanne K. Kjaer

University of Copenhagen

Publications: 91

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 86

Cosette M. Wheeler

Cosette M. Wheeler

University of New Mexico

Publications: 86

Lauri E. Markowitz

Lauri E. Markowitz

National Center for Immunization and Respiratory Diseases

Publications: 81

Elizabeth R. Unger

Elizabeth R. Unger

Centers for Disease Control and Prevention

Publications: 81

Allan Hildesheim

Allan Hildesheim

National Institutes of Health

Publications: 79

Joel M. Palefsky

Joel M. Palefsky

University of California, San Francisco

Publications: 78

Trending Scientists

Denis Gillet

Denis Gillet

École Polytechnique Fédérale de Lausanne

Wim Groot

Wim Groot

Maastricht University

Van Jacobson

Van Jacobson

University of California, Los Angeles

Martin C. Nuss

Martin C. Nuss

Nokia (United States)

David W. Thieltges

David W. Thieltges

Utrecht University

Juan A. Correa

Juan A. Correa

Pontificia Universidad Católica de Chile

Cesare Gessler

Cesare Gessler

ETH Zurich

Baojing Gu

Baojing Gu

Zhejiang University

Todd V. Royer

Todd V. Royer

Indiana University

Matthew R. Longo

Matthew R. Longo

Birkbeck, University of London

Matthew L. Albert

Matthew L. Albert

Genentech

Janusz K. Rybakowski

Janusz K. Rybakowski

Poznan University of Medical Sciences

Klim McPherson

Klim McPherson

University of London

Bertil Lindahl

Bertil Lindahl

Uppsala University

Neil Pearce

Neil Pearce

University of London

Nasar Meer

Nasar Meer

University of Edinburgh

Something went wrong. Please try again later.